These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cardiovascular issues of COX-2 inhibitors and NSAIDs. Wong M; Chowienczyk P; Kirkham B Aust Fam Physician; 2005 Nov; 34(11):945-8. PubMed ID: 16299629 [TBL] [Abstract][Full Text] [Related]
7. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs. Spalding WM; Reeves MJ; Whelton A Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs. Joshi GP; Gertler R; Fricker R Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance. Borer JS; Simon LS Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S14-22. PubMed ID: 16168077 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice. Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789 [TBL] [Abstract][Full Text] [Related]
15. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly. Stillman MJ; Stillman MT Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094 [TBL] [Abstract][Full Text] [Related]
16. COX-2 selective inhibitors in the treatment of osteoarthritis. Laine L; White WB; Rostom A; Hochberg M Semin Arthritis Rheum; 2008 Dec; 38(3):165-87. PubMed ID: 18177922 [TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs and the heart: what is the danger? Mukherjee D Congest Heart Fail; 2008; 14(2):75-82. PubMed ID: 18401215 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of the selective cyclooxygenase-2 inhibitors. White WB Subcell Biochem; 2007; 42():145-58. PubMed ID: 17612049 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease. Ross SJ; Elgendy IY; Bavry AA Curr Cardiol Rep; 2017 Jan; 19(1):8. PubMed ID: 28138824 [TBL] [Abstract][Full Text] [Related]
20. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Hermann M; Ruschitzka F Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]